Scott Henry
Stock Analyst at Alliance Global Partners
(1.25)
# 3,723
Out of 5,149 analysts
60
Total ratings
37.74%
Success rate
-5.95%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $0.80 | +273.37% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $0.93 | +301.76% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $1.41 | +325.53% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $8.84 | +13.12% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $41 | $11.77 | +250.47% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $8.09 | +5.07% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $0.88 | +353.62% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $3.30 | +354.55% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $0.23 | +5,117.39% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $6.07 | +23.56% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $8.93 | +45.58% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $33.34 | -28.01% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $202.55 | -55.57% | 9 | Dec 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $23.88 | -35.09% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $107.40 | -45.99% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $103.74 | -65.30% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.41 | +680.14% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $4.59 | +30.72% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $0.82 | +701,119.51% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.14 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $0.75 | +832.71% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $13.98 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.43 | - | 2 | Mar 26, 2018 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $0.80
Upside: +273.37%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $0.93
Upside: +301.76%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $1.41
Upside: +325.53%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $8.84
Upside: +13.12%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $41
Current: $11.77
Upside: +250.47%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $8.09
Upside: +5.07%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $0.88
Upside: +353.62%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $3.30
Upside: +354.55%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $0.23
Upside: +5,117.39%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $6.07
Upside: +23.56%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $8.93
Upside: +45.58%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $33.34
Upside: -28.01%
Dec 23, 2022
Maintains: Buy
Price Target: $85 → $90
Current: $202.55
Upside: -55.57%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $23.88
Upside: -35.09%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $107.40
Upside: -45.99%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $103.74
Upside: -65.30%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $1.41
Upside: +680.14%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $4.59
Upside: +30.72%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $0.82
Upside: +701,119.51%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.14
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $0.75
Upside: +832.71%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $13.98
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $1.43
Upside: -